Health Care & Life Sciences » Pharmaceuticals | Kangmei Pharmaceutical Co. Ltd.

Kangmei Pharmaceutical Co. Ltd. A | Mutual Funds

Mutual Funds that own Kangmei Pharmaceutical Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
China 50 ETF
22,738,045
0.52%
2,357,558
1.44%
12/31/2017
21,560,133
0.49%
-9,334,200
1.08%
12/31/2017
10,135,564
0.23%
-1,882,700
7.26%
12/31/2017
9,088,736
0.21%
-6,198,605
6.03%
12/31/2017
Shanghai SSE180
7,559,834
0.17%
-367,100
0.93%
12/31/2017
China AMC Income Fund
6,213,137
0.14%
-2,030,200
5.41%
12/31/2017
6,187,663
0.14%
-9,012,731
0.25%
12/31/2017
Huatai - PineBridge CSI 300 ETF Units
5,137,487
0.12%
-300,045
0.64%
12/31/2017
4,746,898
0.11%
0
7.09%
12/31/2017
China AMC CSI 300 Index ETF (CN)
4,641,589
0.11%
-116,700
0.63%
12/31/2017

About Kangmei Pharmaceutical Co.

View Profile
Address
Xiameilin Taike Road
Shenzhen Guangdong 518000
China
Employees -
Website http://www.kangmei.com.cn
Updated 07/08/2019
Kangmei Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical, health care and health food products. It offers Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others, as well as chemical drugs, including Clarithromycin Dispersible Tablets, Doxazosin Mesylate Tablets, Propiverine Hydrochloride Tablets and paracetamol and pseudoephedrine hydrochloride tablets, among others. The company also provides property management services.